Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Do Psychiatric Guidelines Recognise Cannabis for Mood Disorders? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The current state of psychiatric guidelines on cannabis shows that cannabis is not formally recommended for depression, bipolar disorder, or other mood disorders. Most psychiatric associations highlight that the evidence base remains too limited and inconsistent to support cannabis as a frontline treatment. For patients with a mental health condition, this means cannabis use is usually considered only when conventional therapies have failed. 

Although there is growing interest in CBD and its calming effects, psychiatrists remain cautious. The lack of large-scale trials and concerns over potential risks with THC continue to influence the cautious stance reflected in clinical guidelines and cannabis discussions. 

Can I use Medical Cannabis for Pain Relief?

Professional Positions on Cannabis 

Examining psychiatric guidelines on cannabis highlights how mental health professionals and organisations approach the issue. 

Clinical Guidelines for Cannabis 

Current clinical guidelines for cannabis focus on advising against routine use for psychiatric care, pointing instead to therapies with stronger evidence such as antidepressants and psychotherapy. 

Psychiatry Position on Cannabis 

The prevailing psychiatry position on cannabis is one of caution. While acknowledging patient-reported benefits, psychiatrists emphasise the risks of dependency, mood destabilisation, and uncertain long-term outcomes. 

Guideline for Mood Disorders 

Within the guidelines for mood disorders, cannabis is generally mentioned as experimental. Its use is recommended only under specialist supervision and not as a substitute for established treatments. 

In summary, psychiatric guidelines on cannabis do not currently recognise it as a standard treatment for depression or bipolar. Future research may shift this position, but for now it remains outside mainstream psychiatric care. 

For individuals considering cannabis as part of their treatment, providers like LeafEase can offer safe and professional consultations tailored to personal needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories